The Economic Burden of Moderate-to-Severe Multiple Sclerosis Relapse in the United States: Findings from a Systematic Literature Review (P3.402)

Conclusions:Current literature underappreciates the economic burden of moderate-to-severe MS relapse in terms of frequency, duration, and impacts. Exploration into implications for relapse awareness, characterization, and management, including a thorough evaluation of available treatment options, is warranted.Study Supported by: Mallinckrodt PharmaceuticalsDisclosure: Ms. Nazareth has received personal compensation for activities with Mallinckrodt Pharmaceuticals. Dr. Purser has nothing to disclose. Dr. Bhaila has nothing to disclose. Dr. Philbin has received personal compensation for activities with Mallinckrodt Pharmaceuticals as an employee. Dr. Philbin has received research support from Mallinckrodt Pharmaceuticals. Dr. Mladsi has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Economic Implications of Multiple Sclerosis Source Type: research